Are sodium-glucose co-transporter-2 inhibitors associated with improved outcomes in diabetic patients admitted to intensive care units with septic shock?
Nikita AshcherkinAbdelmohaymin A AbdallaSimran GuptaShubhang BhattClaire I YeeRodrigo Cartin-Ceba
Published in: Acute and critical care (2024)
Our study found that diabetic patients on SGLT2i prior to hospitalization who were admitted to the ICU with septic shock had lower inpatient mortality compared to patients not on SGLT2i.